Sign in

CIK 0001370053

  • Non-accelerated filer
  • Smaller reporting company

ANAPTYSBIO, INC

Sign in to watch
Ticker
ANAB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
203828755
Phone
+1 858-362-6295
Business address
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
Former names
ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$249,372
in 1 filing, $249K under 10b5-1 plans

Net −$249,372. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. RENTON HOLLINGS −$249K Director sold 31% of stake

Reading 67 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-11-16 Topper James N Director Other acquisition +26,354 80,812
2020-07-30 Lizzul Paul F. Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +90,000 90,000
2020-07-13 LOUMEAU ERIC J COO, General Counsel Grant or award · Employee Stock Option (Right to Buy) +10,000 10,000
2020-07-13 MULROY DENNIS Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +90,600 90,600
2020-03-10 Suria Hamza President, CEO Exercise or conversion +10,000 $1.12 $11K 47,636
2020-03-10 Suria Hamza President, CEO Exercise or conversion · Employee Stock Option (Right to Buy) −10,000 40,361
2020-02-12 Ware J. Anthony Director Grant or award · Director Stock Option (Right to Buy) +11,000 11,000
2020-02-12 Topper James N Director Grant or award · Director Stock Option (Right to Buy) +11,000 11,000
2020-02-12 Schmid John P. Director Grant or award · Director Stock Option (Right to Buy) +11,000 11,000
2020-02-12 RENTON HOLLINGS Director Grant or award · Director Stock Option (Right to Buy) +11,000 11,000
2020-02-12 Hamill Laura Director Grant or award · Director Stock Option (Right to Buy) +11,000 11,000
2020-02-12 FENTON DENNIS M Director Grant or award · Director Stock Option (Right to Buy) +11,000 11,000
2020-02-05 Suria Hamza President, CEO Exercise or conversion +10,000 $1.12 $11K 37,636
2020-02-05 Suria Hamza President, CEO Exercise or conversion · Employee Stock Option (Right to Buy) −10,000 50,361
2019-12-13 Suria Hamza President, CEO Grant or award · Employee Stock Option (Right to Buy) +280,000 280,000
2019-12-10 Ware J. Anthony Director Purchase +3,600 $14.05 $51K 3,600
2019-12-06 LOUMEAU ERIC J General Counsel & Interim CFO Grant or award · Employee Stock Option (Right to Buy) +98,000 98,000
2019-12-06 Londei Marco Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +98,000 98,000
2019-11-27 Londei Marco Chief Medical Officer Exercise or conversion +46,202 $6.93 $320K 68,579
2019-11-27 Londei Marco Chief Medical Officer Exercise or conversion · Employee Stock Option (Right to Buy) −46,202 4,946

Page 26 of 27 · 522 trades